The Role of the Pharmacist in Managing Type 2 Diabetes with Glucagon-Like Peptide-1 Receptor Agonists as Add-On Therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works matching AU Meece, Jerry
Results: 6
1
2
Pharmacokinetics and Pharmacodynamics of Liraglutide, a Long-Acting, Potent Glucagon-Like Peptide-1 Analog.
- Published in:
- Pharmacotherapy, 2009, v. 29, n. 12, p. 33S, doi. 10.1592/phco.29.pt2.33S
- By:
- Publication type:
- Article
3
Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies.
- Published in:
- 2007
- By:
- Publication type:
- journal article
4
Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies.
- Published in:
- Current Medical Research & Opinion, 2007, v. 23, n. 4, p. 933, doi. 10.1185/030079906X167336
- By:
- Publication type:
- Article
5
Improving Medication Adherence Among Patients With Type 2 Diabetes.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
6
Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 877, doi. 10.1007/s13300-018-0395-3
- By:
- Publication type:
- Article